<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
doi: 10.1007/bf01719944
pmid: 7489772
Data concerning the HBsAg subtype distribution in Spain are out-of-date and confined to a restricted geographical area. Furthermore, the complex distribution observed in the countries surrounding Spain prevents any prediction. To obtain further data on HBsAg subtype distribution among Spanish HBsAg carriers, subtyping analysis (d and y determinants) was performed in 670 samples from subjects belonging to various epidemiological risk groups and coming from different geographical areas of the country. Similar frequencies were found for both mutually exclusive d/y subtype determinants among non-risk, normal HBsAg carriers from almost all geographical areas studied. In contrast, the ay subtype was clearly predominant (79-87%) among intravenous drug users, irrespective of their geographical origin. Thirteen different institutions for mentally retarded patients behaved as closed communities for HBV circulation, showing independent subtype distributions. Thus, no significant geographical variations were found for HBsAg subtype distribution in Spain. The prevalence of each particular subtype is mainly dependent on the epidemiological characteristics of the carriers studied. Subtype distribution was independent of the presence of HBeAg or HDV infection serum markers when homogeneous groups were considered separately. Atypical HBsAg phenotypes, either with coexistence or absence of both subtype determinants, were found in some cases.
Adult, Male, Hepatitis B virus, Hepatitis B Surface Antigens, Antibodies, Monoclonal, Hepatitis B, Sensitivity and Specificity, Hepatitis D, Immunoenzyme Techniques, Spain, Intellectual Disability, Carrier State, Prevalence, Humans, Female, Hepatitis B e Antigens, Hepatitis B Antibodies, Hepatitis Delta Virus, Substance Abuse, Intravenous
Adult, Male, Hepatitis B virus, Hepatitis B Surface Antigens, Antibodies, Monoclonal, Hepatitis B, Sensitivity and Specificity, Hepatitis D, Immunoenzyme Techniques, Spain, Intellectual Disability, Carrier State, Prevalence, Humans, Female, Hepatitis B e Antigens, Hepatitis B Antibodies, Hepatitis Delta Virus, Substance Abuse, Intravenous
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |